National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

tocophersolan
A water-soluble amphipathic formulation of d-alpha-tocopherol succinate coupled, through a succinate linker, to polyethylene glycol (PEG) 1000. Due to its amphipathic property in which it forms its own micelles, tocophersolan is easily taken up into enterocytes, even in the absence of bile salts; fat soluble d-alpha-tocopherol is then released after hydrolysis. This formulation enhances the absorption of d-alpha-tocopherol compared to the administration of free d-alpha-tocopherol. In addition, tocophersolan may enhance the absorption of water-insoluble agents and other fat-soluble vitamins. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:d-alpha tocopheryl polyethylene glycol 1000 succinate
d-alpha-tocopheryl polyethylene glycol 1000 succinate
Abbreviation:vitamin E PEG-1000-succinate
Acronym:TPGS



Previous:TLR9 agonist IMO-2055, TNFerade, TNP-470, tobramycin sulfate, Tobrex
Next:Tocosol Paclitaxel, Tomudex, topical betulinic acid, topical gemcitabine hydrochloride, topical myristyl nicotinate cream

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov